These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 37782962)

  • 1. Combined stent retriever angioplasty and continuous intra-arterial nimodipine infusion as salvage therapy for cerebral vasospasm and delayed cerebral ischemia after subarachnoid hemorrhage: illustrative case.
    Knoll A; Durner G; Braun M; Schmitz B; Wirtz CR; König R; Pala A
    J Neurosurg Case Lessons; 2023 Oct; 6(14):. PubMed ID: 37782962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The evolution of invasive cerebral vasospasm treatment in patients with spontaneous subarachnoid hemorrhage and delayed cerebral ischemia-continuous selective intracarotid nimodipine therapy in awake patients without sedation.
    Paľa A; Schneider M; Brand C; Pedro MT; Özpeynirci Y; Schmitz B; Wirtz CR; Kapapa T; König R; Braun M
    Neurosurg Rev; 2019 Jun; 42(2):463-469. PubMed ID: 29804157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous intra-arterial nimodipine infusion as rescue treatment of severe refractory cerebral vasospasm after aneurysmal subarachnoid hemorrhage.
    Anthofer J; Bele S; Wendl C; Kieninger M; Zeman F; Bruendl E; Schmidt NO; Schebesch KM
    J Clin Neurosci; 2022 Feb; 96():163-171. PubMed ID: 34789415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endovascular therapy for vasospasm after aneurysmatic subarachnoid hemorrhage.
    Kerz T; Boor S; Ulrich A; Beyer C; Hechtner M; Mueller-Forell W
    Br J Neurosurg; 2016 Oct; 30(5):549-53. PubMed ID: 27080311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Higher dose intra-arterial milrinone and intra-arterial combined milrinone-nimodipine infusion as a rescue therapy for refractory cerebral vasospasm.
    Duman E; Karakoç F; Pinar HU; Dogan R; Fırat A; Yıldırım E
    Interv Neuroradiol; 2017 Dec; 23(6):636-643. PubMed ID: 28956512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous intra-arterial nimodipine infusion in patients with severe refractory cerebral vasospasm after aneurysmal subarachnoid hemorrhage: a feasibility study and outcome results.
    Bele S; Proescholdt MA; Hochreiter A; Schuierer G; Scheitzach J; Wendl C; Kieninger M; Schneiker A; Bründl E; Schödel P; Schebesch KM; Brawanski A
    Acta Neurochir (Wien); 2015 Dec; 157(12):2041-50. PubMed ID: 26439105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complication rate of intraarterial treatment of severe cerebral vasospasm after subarachnoid hemorrhage with nimodipine and percutaneous transluminal balloon angioplasty: Worth the risk?
    Adami D; Berkefeld J; Platz J; Konczalla J; Pfeilschifter W; Weidauer S; Wagner M
    J Neuroradiol; 2019 Feb; 46(1):15-24. PubMed ID: 29733918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of Cerebral Vasospasm With Continuous Intra-Arterial Nimodipine: A Case Report.
    Barbosa S; Jorge N; Silva ML; Maia I; Dias C; Pereira E; Paiva JA
    Cureus; 2022 Oct; 14(10):e30507. PubMed ID: 36415418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-Term, Continuous Intra-Arterial Nimodipine Treatment of Severe Vasospasm After Aneurysmal Subarachnoid Hemorrhage.
    Hockel K; Diedler J; Steiner J; Birkenhauer U; Danz S; Ernemann U; Schuhmann MU
    World Neurosurg; 2016 Apr; 88():104-112. PubMed ID: 26732964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemodynamic response and clinical outcome following intravenous milrinone plus norepinephrine-based hyperdynamic hypertensive therapy in patients suffering secondary cerebral ischemia after aneurysmal subarachnoid hemorrhage.
    Steiger HJ; Ensner R; Andereggen L; Remonda L; Berberat J; Marbacher S
    Acta Neurochir (Wien); 2022 Mar; 164(3):811-821. PubMed ID: 35138488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Side Effects of Long-Term Continuous Intra-arterial Nimodipine Infusion in Patients with Severe Refractory Cerebral Vasospasm after Subarachnoid Hemorrhage.
    Kieninger M; Flessa J; Lindenberg N; Bele S; Redel A; Schneiker A; Schuierer G; Wendl C; Graf B; Silbereisen V
    Neurocrit Care; 2018 Feb; 28(1):65-76. PubMed ID: 28685393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of Angiographic Treatment Response to Intra-Arterial Nimodipine Bolus Injection in Patients with Medically Refractory Cerebral Vasospasm After Spontaneous Subarachnoid Hemorrhage.
    Schacht H; Küchler J; Neumann A; Schramm P; Tronnier VM; Ditz C
    World Neurosurg; 2022 Jun; 162():e457-e467. PubMed ID: 35292409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Side effects of continuous intra-arterial infusion of nimodipine for management of resistant cerebral vasospasm in subarachnoid hemorrhage patients: A systematic review.
    Viderman D; Sarria-Santamera A; Bilotta F
    Neurochirurgie; 2021 Sep; 67(5):461-469. PubMed ID: 33652066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aggressive management of vasospasm with direct intra-arterial nimodipine therapy.
    Narayan V; Pendharkar H; Devi BI; Bhat DI; Shukla DP
    Neurol India; 2018; 66(2):416-422. PubMed ID: 29547164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel Treatment of Cerebral Vasospasm Using Solitaire Stent Retriever-Assisted Angioplasty: Case Series.
    Su YS; Ali MS; Pukenas BA; Favilla CG; Zanaty M; Hasan DM; Kung DK
    World Neurosurg; 2020 Mar; 135():e657-e663. PubMed ID: 31881345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nimodipine vs. Milrinone - Equal or Complementary Use? A Retrospective Analysis.
    Jentzsch J; Ziganshyna S; Lindner D; Merkel H; Mucha S; Schob S; Quäschling U; Hoffmann KT; Werdehausen R; Halama D; Gaber K; Richter C
    Front Neurol; 2022; 13():939015. PubMed ID: 35911878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Course and Monitoring Parameters After Continuous Interventional Intra-Arterial Treatment in Patients with Refractory Cerebral Vasospasm.
    von der Brelie C; Doukas A; Stopfer A; Larsen N; Mehdorn M; Synowitz M; Jansen O
    World Neurosurg; 2017 Apr; 100():504-513. PubMed ID: 28131927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of nimodipine and vasopressors on outcome in patients with delayed cerebral ischemia after spontaneous subarachnoid hemorrhage.
    Paľa A; Schick J; Klein M; Mayer B; Schmitz B; Wirtz CR; König R; Kapapa T
    J Neurosurg; 2019 Mar; 132(4):1096-1104. PubMed ID: 30849754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is Stent Retraction to ReLieve Arterial Cerebral VaSospasm Caused by SAH (Stent-ReLACSS) Using PRELAX the Long-awaited Solution for Treatment of Posthemorrhagic Cerebral Vasospasm? : Treatment of Posthemorrhagic Cerebral Vasospasm with PRESET and PRELAX: Technical Aspects, Efficacy, and Safety Margins in a Case Series.
    Khanafer A; von Gottberg P; Albiña-Palmarola P; Liebig T; Forsting M; Ganslandt O; Henkes H
    Clin Neuroradiol; 2024 Apr; ():. PubMed ID: 38634888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous selective intra-arterial application of nimodipine in refractory cerebral vasospasm due to aneurysmal subarachnoid hemorrhage.
    Ott S; Jedlicka S; Wolf S; Peter M; Pudenz C; Merker P; Schürer L; Lumenta CB
    Biomed Res Int; 2014; 2014():970741. PubMed ID: 24527461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.